The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
Open accessAbstract
Chloroquine (CQ) and hydroxychloroquine (HCQ) are well-known 4-aminoquinoline antimalarial agents. Scientific evidence also supports the use of CQ and HCQ in the treatment of cancer. Overall, preclinical studies support CQ and HCQ use in anti-cancer therapy, especially in combination with conventional anti-cancer treatments since they are able to sensitise tumour cells to a variety of drugs, potentiating the therapeutic activity. Thus far, clinical results are mostly in favour of the repurposing of CQ. However, over 30 clinical studies are still evaluating the activity of both CQ and HCQ in different cancer types and in combination with various standard treatments. Interestingly, CQ and HCQ exert effects both on cancer cells and on the tumour microenvironment. In addition to inhibition of the autophagic flux, which is the most studied anti-cancer effect of CQ and HCQ, these drugs affect the Toll-like receptor 9, p53 and CXCR4-CXCL12 pathway in cancer cells. In the tumour stroma, CQ was shown to affect the tumour vasculature, cancer-associated fibroblasts and the immune system. The evidence reviewed in this paper indicates that both CQ and HCQ deserve further clinical investigations in several cancer types. Special attention about the drug (CQ versus HCQ), the dose and the schedule of administration should be taken in the design of new trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Autophagy: cellular and molecular mechanisms
Glick, D., Barth, S., & Macleod, K. F. (2010) · The Journal of Pathology · doi:10.1002/path.2697 · Cited by 3,802
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
An Overview of Autophagy: Morphology, Mechanism, and Regulation
Parzych, K. R., & Klionsky, D. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5371 · Cited by 2,521
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
Pancreatic cancers require autophagy for tumor growth
Yang, S., Wang, X., Contino, G., Liesa, M., Sahin, E., Ying, H., Bause, A., Li, Y., Stommel, J. M., Dell'Antonio, G., et al. (2011) · Genes & Development · doi:10.1101/gad.2016111 · Cited by 1,498
Unravelling mechanisms of p53-mediated tumour suppression
Bieging, K. T., Mello, S. S., & Attardi, L. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3711 · Cited by 1,387
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
Marmor, M. F., Kellner, U., Lai, T. Y. Y., Melles, R. B., & Mieler, W. F. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.058 · Cited by 1,164
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
Amaravadi, R. K., Yu, D., Lum, J. J., Bui, T., Christophorou, M. A., Evan, G. I., Thomas-Tikhonenko, A., & Thompson, C. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28833 · Cited by 1,137
Polypharmacology: Challenges and Opportunities in Drug Discovery: Miniperspective
Anighoro, A., Bajorath, J., & Rastelli, G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5006463 · Cited by 1,131
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 966
Rouschop, K. M. A., van den Beucken, T., Dubois, L., Niessen, H., Bussink, J., Savelkouls, K., Keulers, T., Mujcic, H., Landuyt, W., Voncken, J. W., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40027 · Cited by 829
Autophagy as a target for anticancer therapy
Janku, F., McConkey, D. J., Hong, D. S., & Kurzrock, R. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.71 · Cited by 803
Multicomponent therapeutics for networked systems
Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1609 · Cited by 769
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
Sun, X., Cheng, G., Hao, M., Zheng, J., Zhou, X., Zhang, J., Taichman, R. S., Pienta, K. J., & Wang, J. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9256-x · Cited by 727
p53 status determines the role of autophagy in pancreatic tumour development
Rosenfeldt, M. T., O’Prey, J., Morton, J. P., Nixon, C., MacKay, G., Mrowinska, A., Au, A., Rai, T. S., Zheng, L., Ridgway, R., et al. (2013) · Nature · doi:10.1038/nature12865 · Cited by 713
Hydroxychloroquine: From Malaria to Autoimmunity
Ben-Zvi, I., Kivity, S., Langevitz, P., & Shoenfeld, Y. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8243-x · Cited by 613
Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines
Kužnik, A., Benčina, M., Švajger, U., Jeras, M., Rozman, B., & Jerala, R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000702 · Cited by 606
Bellodi, C., Lidonnici, M. R., Hamilton, A., Helgason, G. V., Soliera, A. R., Ronchetti, M., Galavotti, S., Young, K. W., Selmi, T., Yacobi, R., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35660 · Cited by 570
Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies
Solomon, V. R., & Lee, H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.063 · Cited by 516
Rosenfeld, M. R., Ye, X., Supko, J. G., Desideri, S., Grossman, S. A., Brem, S., Mikkelson, T., Wang, D., Chang, Y. C., Hu, J., et al. (2014) · Autophagy · doi:10.4161/auto.28984 · Cited by 515
Sotelo, J., Briceño, E., & López-González, M. A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00008 · Cited by 505
Chloroquine in Cancer Therapy: A Double-Edged Sword of Autophagy
Kimura, T., Takabatake, Y., Takahashi, A., & Isaka, Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2464 · Cited by 494
Hu, Y.-L., DeLay, M., Jahangiri, A., Molinaro, A. M., Rose, S. D., Carbonell, W. S., & Aghi, M. K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3831 · Cited by 483
Glutaminolysis as a target for cancer therapy
Jin, L., Alesi, G. N., & Kang, S. (2016) · Oncogene · doi:10.1038/onc.2015.447 · Cited by 459
Rangwala, R., Chang, Y. C., Hu, J., Algazy, K. M., Evans, T. L., Fecher, L. A., Schuchter, L. M., Torigian, D. A., Panosian, J. T., Troxel, A. B., et al. (2014) · Autophagy · doi:10.4161/auto.29119 · Cited by 424
McAfee, Q., Zhang, Z., Samanta, A., Levi, S. M., Ma, X.-H., Piao, S., Lynch, J. P., Uehara, T., Sepulveda, A. R., Davis, L. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118193109 · Cited by 422
Tumor Vessel Normalization by Chloroquine Independent of Autophagy
Maes, H., Kuchnio, A., Peric, A., Moens, S., Nys, K., De Bock, K., Quaegebeur, A., Schoors, S., Georgiadou, M., Wouters, J., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.025 · Cited by 410
Self-citationChloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy
Maycotte, P., Aryal, S., Cummings, C. T., Thorburn, J., Morgan, M. J., & Thorburn, A. (2012) · Autophagy · doi:10.4161/auto.8.2.18554 · Cited by 401
Wolpin, B. M., Rubinson, D. A., Wang, X., Chan, J. A., Cleary, J. M., Enzinger, P. C., Fuchs, C. S., McCleary, N. J., Meyerhardt, J. A., Ng, K., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0086 · Cited by 374
Vogl, D. T., Stadtmauer, E. A., Tan, K.-S., Heitjan, D. F., Davis, L. E., Pontiggia, L., Rangwala, R., Piao, S., Chang, Y. C., Scott, E. C., et al. (2014) · Autophagy · doi:10.4161/auto.29264 · Cited by 368
Rangwala, R., Leone, R., Chang, Y. C., Fecher, L. A., Schuchter, L. M., Kramer, A., Tan, K.-S., Heitjan, D. F., Rodgers, G., Gallagher, M., et al. (2014) · Autophagy · doi:10.4161/auto.29118 · Cited by 367
Shi, Y.-H., Ding, Z.-B., Zhou, J., Hui, B., Shi, G.-M., Ke, A.-W., Wang, X.-Y., Dai, Z., Peng, Y.-F., Gu, C.-Y., et al. (2011) · Autophagy · doi:10.4161/auto.7.10.16818 · Cited by 344
Mahalingam, D., Mita, M., Sarantopoulos, J., Wood, L., Amaravadi, R. K., Davis, L. E., Mita, A. C., Curiel, T. J., Espitia, C. M., Nawrocki, S. T., et al. (2014) · Autophagy · doi:10.4161/auto.29231 · Cited by 285
Emerging strategies to effectively target autophagy in cancer
Rebecca, V. W., & Amaravadi, R. K. (2016) · Oncogene · doi:10.1038/onc.2015.99 · Cited by 278
Maclean, K. H., Dorsey, F. C., Cleveland, J. L., & Kastan, M. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33700 · Cited by 272
Shimizu, S., Takehara, T., Hikita, H., Kodama, T., Tsunematsu, H., Miyagi, T., Hosui, A., Ishida, H., Tatsumi, T., Kanto, T., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26374 · Cited by 266
Martinez-Outschoorn, U. E., Pavlides, S., Whitaker-Menezes, D., Daumer, K. M., Milliman, J. N., Chiavarina, B., Migneco, G., Witkiewicz, A. K., Martinez-Cantarin, M. P., Flomenberg, N., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.12.12048 · Cited by 246
Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
Levy, J. M. M., Thompson, J. C., Griesinger, A. M., Amani, V., Donson, A. M., Birks, D. K., Morgan, M. J., Mirsky, D. M., Handler, M. H., Foreman, N. K., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0049 · Cited by 246
The role of antimalarial agents in the treatment of SLE and lupus nephritis
Lee, S.-J., Silverman, E., & Bargman, J. M. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.150 · Cited by 241
Boone, B. A., Bahary, N., Zureikat, A. H., Moser, A. J., Normolle, D. P., Wu, W.-C., Singhi, A. D., Bao, P., Bartlett, D. L., Liotta, L. A., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4566-4 · Cited by 234
Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy
Eng, C. H., Wang, Z., Tkach, D., Toral-Barza, L., Ugwonali, S., Liu, S., Fitzgerald, S. L., George, E., Frias, E., Cochran, N., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515617113 · Cited by 227
Pellegrini, P., Strambi, A., Zipoli, C., Hägg-Olofsson, M., Buoncervello, M., Linder, S., & De Milito, A. (2014) · Autophagy · doi:10.4161/auto.27901 · Cited by 226
Chloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer
Cook, K. L., Wärri, A., Soto-Pantoja, D. R., Clarke, P. A., Cruz, M. I., Zwart, A., & Clarke, R. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3227 · Cited by 226
Autophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy
Selvakumaran, M., Amaravadi, R. K., Vasilevskaya, I. A., & O'Dwyer, P. J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1542 · Cited by 221
Autophagy inhibition enhances vorinostat‐induced apoptosis via ubiquitinated protein accumulation
Carew, J. S., Medina, E. C., Esquivel II, J. A., Mahalingam, D., Swords, R., Kelly, K., Zhang, H., Huang, P., Mita, A. C., Mita, M. M., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00832.x · Cited by 219
(2010) · Neuro-Oncology · doi:10.1093/neuonc/nop048 · Cited by 217
Wei, M.-F., Chen, M.-W., Chen, K.-C., Lou, P.-J., Lin, S. Y.-F., Hung, S.-C., Hsiao, M., Yao, C.-J., & Shieh, M.-J. (2014) · Autophagy · doi:10.4161/auto.28679 · Cited by 205
Zanotto-Filho, A., Braganhol, E., Klafke, K., Figueiró, F., Terra, S. R., Paludo, F. J., Morrone, M., Bristot, I. J., Battastini, A. M., Forcelini, C. M., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.12.044 · Cited by 196
Antimalarials in the management of discoid and systemic lupus erythematosus
L. Dubois, E. (1978) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(78)90033-1 · Cited by 189
Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine
Briceño, E., Reyes, S., & Sotelo, J. (2003) · Neurosurgical Focus · doi:10.3171/foc.2003.14.2.4 · Cited by 185
Maycotte, P., Gearheart, C. M., Barnard, R., Aryal, S., Mulcahy Levy, J. M., Fosmire, S. P., Hansen, R. J., Morgan, M. J., Porter, C. C., Gustafson, D. L., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3470 · Cited by 185
Pharmacology of Chloroquine and Hydroxychloroquine
Browning, D. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0597-3_2 · Cited by 179
Guo, X.-L., Li, D., Hu, F., Song, J.-R., Zhang, S.-S., Deng, W.-J., Sun, K., Zhao, Q.-D., Xie, X.-Q., Song, Y.-J., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.002 · Cited by 179
Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy
Golden, E. B., Cho, H.-Y., Jahanian, A., Hofman, F. M., Louie, S. G., Schönthal, A. H., & Chen, T. C. (2014) · Neurosurgical Focus · doi:10.3171/2014.9.focus14504 · Cited by 179
Ding, Z.-B., Hui, B., Shi, Y.-H., Zhou, J., Peng, Y.-F., Gu, C.-Y., Yang, H., Shi, G.-M., Ke, A.-W., Wang, X.-Y., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0816 · Cited by 178
Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells
Fan, C., Wang, W., Zhao, B., Zhang, S., & Miao, J. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.035 · Cited by 176
Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors
Mulcahy Levy, J. M., Zahedi, S., Griesinger, A. M., Morin, A., Davies, K. D., Aisner, D. L., Kleinschmidt-DeMasters, B., Fitzwalter, B. E., Goodall, M. L., Thorburn, J., et al. (2017) · eLife · doi:10.7554/elife.19671 · Cited by 175
Ko, Y.-H., Lin, Z., Flomenberg, N., Pestell, R. G., Howell, A., Sotgia, F., Lisanti, M. P., & Martinez-Outschoorn, U. E. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.12.18671 · Cited by 173
Lefort, S., Joffre, C., Kieffer, Y., Givel, A.-M., Bourachot, B., Zago, G., Bieche, I., Dubois, T., Meseure, D., Vincent-Salomon, A., et al. (2014) · Autophagy · doi:10.4161/15548627.2014.981788 · Cited by 173
(2016) · ecancermedicalscience · doi:10.3332/ecancer.2014.442 · Cited by 173
A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non–Small-Cell Lung Cancer
Goldberg, S. B., Supko, J. G., Neal, J. W., Muzikansky, A., Digumarthy, S., Fidias, P., Temel, J. S., Heist, R. S., Shaw, A. T., McCarthy, P. O., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318262de4a · Cited by 170
Song, Y.-J., Zhang, S.-S., Guo, X.-L., Sun, K., Han, Z.-P., Li, R., Zhao, Q.-D., Deng, W.-J., Xie, X.-Q., zhang, J.-W., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.021 · Cited by 164
Inhibiting Systemic Autophagy during Interleukin 2 Immunotherapy Promotes Long-term Tumor Regression
Liang, X., De Vera, M. E., Buchser, W. J., de Vivar Chavez, A. R., Loughran, P., Stolz, D. B., Basse, P., Wang, T., Van Houten, B., Zeh, H. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0320 · Cited by 159
Autophagy Suppresses RIP Kinase-Dependent Necrosis Enabling Survival to mTOR Inhibition
Bray, K., Mathew, R., Lau, A., Kamphorst, J. J., Fan, J., Chen, J., Chen, H.-Y., Ghavami, A., Stein, M. N., DiPaola, R. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041831 · Cited by 159
Targeting Autophagy Addiction in Cancer
Mancias, J. D., & Kimmelman, A. C. (2011) · Oncotarget · doi:10.18632/oncotarget.384 · Cited by 154
Chloroquine Targets Pancreatic Cancer Stem Cells via Inhibition of CXCR4 and Hedgehog Signaling
Balic, A., Sørensen, M. D., Trabulo, S. M. D., Sáinz, B., Cioffi, M., Vieira, C. R., Miranda‐Lorenzo, I., Hidalgo, M. M., Kleeff, J. H., Erkan, M., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0948 · Cited by 152
Chloroquine: Modes of action of an undervalued drug
Thomé, R., Lopes, S. C. P., Costa, F. T. M., & Verinaud, L. M. C. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.07.004 · Cited by 152
Coordinate Autophagy and mTOR Pathway Inhibition Enhances Cell Death in Melanoma
Xie, X., White, E. P., & Mehnert, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055096 · Cited by 150
Zou, Y., Ling, Y., Sironi, J., Schwartz, E. L., Perez-Soler, R., & Piperdi, B. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828c7210 · Cited by 149
Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells
Kim, E. L., Wuestenberg, R., Rübsam, A., Schmitz-Salue, C., Warnecke, G., Bucker, E.-M., Pettkus, N., Speidel, D., Rohde, V., Schulz‐Schaeffer, W., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop046 · Cited by 148
Liang, D. H., Choi, D. S., Ensor, J., Kaipparettu, B. A., Bass, B. L., & Chang, J. C. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.002 · Cited by 141
Vesicular Anthracycline Accumulation in Doxorubicin-Selected U-937 Cells: Participation of Lysosomes
Hurwitz, S. J., Terashima, M., Mizunuma, N., & Slapak, C. A. (1997) · Blood · doi:10.1182/blood.v89.10.3745 · Cited by 137
Puentes, L. L. R., González-Pinedo, M., Crismatt, A., Ortega-Gómez, A., Gamboa-Vignolle, C., Núñez-Gómez, R., Dorantes-Gallareta, Y., Arce-Salinas, C., & Arrieta, O. G. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-209 · Cited by 134
Sundelin, S. P., & Terman, A. (2002) · Apmis · doi:10.1034/j.1600-0463.2002.100606.x · Cited by 134
Warhurst, D. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg319 · Cited by 133
Justilien, V., & Fields, A. P. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0507 · Cited by 131
Chloroquine Eliminates Cancer Stem Cells Through Deregulation of Jak2 and DNMT1
Choi, D. S., Blanco, E., Kim, Y.-S., Rodriguez, A. A., Zhao, H., Huang, T. H. ‐., Chen, C., Jin, G., Landis, M. D., Burey, L. A., et al. (2014) · Stem Cells · doi:10.1002/stem.1746 · Cited by 129
A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye
Costedoat-Chalumeau, N., Dunogué, B., Leroux, G., Morel, N., Jallouli, M., Guern, V. L., Pietté, J. C., Brézin, A. P., Melles, R. B., & Marmor, M. F. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8469-8 · Cited by 126
Ding, W., Ni, H., Gao, W., Chen, X., Kang, J. H., Stolz, D. B., Liu, J., & Yin, X. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1169 · Cited by 125
Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme
Briceño, E., Calderón, A., & Sotelo, J. (2007) · Surgical Neurology · doi:10.1016/j.surneu.2006.08.080 · Cited by 124
Dai, J.-P., Zhao, X.-F., Zeng, J., Wan, Q.-Y., Yang, J.-C., Li, W.-Z., Chen, X.-X., Wang, G.-F., & Li, K.-S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061026 · Cited by 123
Cufí, S., Vázquez‐Martín, A., Oliveras‐Ferraros, C., Corominas-Faja, B., Cuyàs, E., López‐Bonet, E., Martín-Castillo, B., Joven, J., & Menéndez, J. A. (2013) · Scientific Reports · doi:10.1038/srep02469 · Cited by 120
Lee, S. W., Kim, H.-K., Lee, N. H., Yi, H.-Y., Kim, H.-S., Hong, S. H., Hong, Y.-K., & Joe, Y. A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.012 · Cited by 119
Molecular Pathways: Autophagy in Cancer—A Matter of Timing and Context
Cicchini, M., Karantza, V., & Xia, B. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2438 · Cited by 118
Yu, L., Gu, C., Zhong, D., Shi, L., Kong, Y., Zhou, Z., & Liu, S. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.020 · Cited by 117
Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies
Pascolo, S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.017 · Cited by 116
Goodall, M. L., Wang, T., Martin, K. R., Kortus, M. G., Kauffman, A. L., Trent, J. M., Gately, S. T., & MacKeigan, J. P. (2014) · Autophagy · doi:10.4161/auto.28594 · Cited by 112
Rao, R., Balusu, R., Fiskus, W. C., Mudunuru, U., Venkannagari, S., Chauhan, L., Smith, J. E., Hembruff, S. L., Ha, K., Atadja, P. W., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0979 · Cited by 112
Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity
Townsend, K. N., Hughson, L. R. K., Schlie, K., Poon, V. I., Westerback, A., & Lum, J. J. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01141.x · Cited by 107
Rahim-Bata, R., & Strobl, J. S. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32832f4e50 · Cited by 105
Regulation of autophagy and chloroquine sensitivity by oncogenic RAS in vitro is context-dependent
Morgan, M. J., Gamez, G., Menke, C., Hernandez, A. L., Thorburn, J., Gidan, F., Staskiewicz, L., Morgan, S. C., Cummings, C. T., Maycotte, P., et al. (2014) · Autophagy · doi:10.4161/auto.32135 · Cited by 105
Inhibition of autophagy attenuates pancreatic cancer growth independent of TP53/TRP53 status
Yang, A., & Kimmelman, A. C. (2014) · Autophagy · doi:10.4161/auto.29961 · Cited by 102
Autophagy: An adaptive metabolic response to stress shaping the antitumor immunity
Viry, E., Paggetti, J., Bagińska, J., Mgrditchian, T., Berchem, G., Moussay, E., & Janji, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.006 · Cited by 101
Dragowska, W. H., Weppler, S. A., Wang, J. C., Wong, L. Y., Kapanen, A. I., Rawji, J. S., Warburton, C., Qadir, M. A., Donohue, E., Roberge, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076503 · Cited by 100
Lee, C. M., & Tannock, I. F. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603010 · Cited by 98
Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs
Vezmar, M., & Georges, E. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00270-7 · Cited by 92
Sun, K., Guo, X.-L., Zhao, Q.-D., Jing, Y.-Y., Kou, X.-R., Xie, X.-Q., Zhou, Y., Cai, N., Gao, L., Zhao, X., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.35 · Cited by 91
Abdel‐Aziz, A. K., Shouman, S. A., El‐Demerdash, E., et al. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.04.007 · Cited by 91
You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia
Sehgal, A. R., Koenig, H., Johnson, D. E., Tang, D., Amaravadi, R. K., Boyiadzis, M. M., & Lotze, M. T. (2014) · Leukemia · doi:10.1038/leu.2014.349 · Cited by 89
Zheng, Y., Zhao, Y., Deng, X., Yang, S., Mao, Y.-Q., Li, Z., Jiang, P., Zhao, X., & Wei, Y. (2009) · Cancer Investigation · doi:10.1080/07357900802427927 · Cited by 88
Molenaar, R. J., Coelen, R. J. S., Khurshed, M., Roos, E., Caan, M. W. A., Linde, M. E. V., Kouwenhoven, M. C. M., Bramer, J. A. M., Bovée, J. V. M. G., Mathôt, R. A. A., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014961 · Cited by 84
Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy
Leung, L.-S. B., Neal, J. W., Wakelee, H. A., Sequist, L. V. D., & Marmor, M. F. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.07.012 · Cited by 82
Jiang, P., Zhao, Y., Deng, X., Mao, Y.-Q., Shi, W., Tang, Q., Li, Z.-G., Zheng, Y., Yang, S., & Wei, Y.-Q. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.06.004 · Cited by 81
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
Tuomela, J. M., Sandholm, J. A., Karihtala, P., Ilvesaro, J. M., Vuopala, K. S., Kauppila, J. H., Kauppila, S., Chen, D., Pressey, C. S., Härkönen, P. L., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2181-7 · Cited by 78
Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma
Shen, J., Zheng, H., Ruan, J., Fang, W., Li, A., Tian, G., Niu, X., Luo, S., & Zhao, P. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.306 · Cited by 77
Chloroquine-Mediated Lysosomal Dysfunction Enhances the Anticancer Effect of Nutrient Deprivation
Harhaji-Trajkovic, L. M., Arsikin, K. M., Kravic‐Stevovic, T., Petricevic, S. M., Tovilović-Kovačević, G., Pantovic, A., Zogovic, N. S., Ristic, B. Z., Janjetović, K., Bumbasirevic, V. Z., et al. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0753-1 · Cited by 77
Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer
Ji, C., Zhang, L., Cheng, Y., Patel, R., Wu, H., Zhang, Y., Wang, M., Ji, S., Belani, C. P., Yang, J., et al. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28162 · Cited by 77
Investigation of nicotine binding to THP-1 cells : evidence for a non-cholinergic binding site
Morgan, D., Parsons, M., & Whelan, C. J. (2001) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.1016/s0006-2952 · Cited by 77
Sasaki, K., Tsuno, N. H., Sunami, E., Kawai, K., Hongo, K., Hiyoshi, M., Kaneko, M., Murono, K., Tada, N., Nirei, T., et al. (2012) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328353f8c7 · Cited by 76
Hui, B., Shi, Y., Ding, Z., Zhou, J., Gu, C., Peng, Y., Yang, H., Liu, W., Shi, G., & Fan, J. (2012) · Cancer · doi:10.1002/cncr.27586 · Cited by 74
Mohamed, F. E. Z. A., Al-Jehani, R. M., Minogue, S., Andreola, F., Winstanley, A. M., Damink, S. W. M. O., Habtesion, A., Malagó, M., Davies, N. A., Luong, T. V., et al. (2014) · Liver International · doi:10.1111/liv.12626 · Cited by 74
Kim, J., Yip, M. L. R., Shen, X., Li, H., Hsin, L.-Y. C., LaBarge, S. A., Heinrich, E. L., Lee, W., Lu, J., & Vaidehi, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031004 · Cited by 73
Burikhanov, R., Hebbar, N., Noothi, S. K., Shukla, N., Sledziona, J., Araújo, N. V. P., Kudrimoti, M., Wang, Q. J., Watt, D. S., Welch, D. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.051 · Cited by 71
Chloroquine Promotes Apoptosis in Melanoma Cells by Inhibiting BH3 Domain–Mediated PUMA Degradation
Lakhter, A. J., Sahu, R. P., Sun, Y., Kaufmann, W. K., Androphy, E. J., Travers, J. B., & Naidu, S. R. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.56 · Cited by 69
Jiang, P., Zhao, Y., Shi, W., Deng, X., ., G. X., Mao, Y.-Q., Li, Z., Zheng, Y., Yang, S., & Wei, Y.-Q. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000185488 · Cited by 69
Zhao, X., Sun, R., Yang, X., Liu, D., Lei, D., Jin, T., & Pan, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126147 · Cited by 66
Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo
Hu, T., Li, P., Luo, Z., Chen, X., Zhang, J., Wang, C., Chen, P., & Dong, Z. (2015) · Oncology Reports · doi:10.3892/or.2015.4380 · Cited by 65
Thomas, S., Sharma, N., Golden, E. B., Cho, H., Agarwal, P., Gaffney, K. J., Petasis, N. A., Chen, T. C., Hofman, F. M., Louie, S. G., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.030 · Cited by 65
Inhibition of autophagy with chloroquine is effective in melanoma
Egger, M. E., Huang, J. S., Yin, W., McMasters, K. M., & McNally, L. R. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.04.055 · Cited by 64
Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107.
Hagihara, N., Walbridge, S., Olson, A. W., Oldfield, E. H., & Youle, R. J. (2000) · PubMed · Cited by 64
Loehberg, C. R., Thompson, T., Kastan, M. B., Maclean, K. H., Edwards, D. G., Kittrell, F. S., Medina, D., Conneely, O. M., & O’Malley, B. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3058 · Cited by 60
Eldredge-Hindy, H., DeNittis, A. S., DuHadaway, J. B., Chernick, M. R., Metz, R. A., & Prendergast, G. C. (2013) · Journal of Radiation Oncology · doi:10.1007/s13566-013-0111-x · Cited by 60
Direct binding of chloroquine to the multidrug resistance protein (MRP)
Vezmar, M., & Georges, E. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00217-2 · Cited by 59
EGFR overexpressing cells and tumors are dependent on autophagy for growth and survival
Jutten, B., Keulers, T. G., Schaaf, M. B. E., Savelkouls, K. G. M., Theys, J., Span, P. N., Vooijs, M., Bussink, J., & Rouschop, K. M. A. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.033 · Cited by 59
Self-citationYou, L., Shou, J., Deng, D., Jiang, L., Zhao, J., Yao, J., Li, H., Xie, J., Wang, Z., Qin, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5592 · Cited by 55
Mitou, G., Frentzel, J., Desquesnes, A., Gonidec, S. L., Saati, T. A., Beau, I., Lamant, L., Meggetto, F., Espinos, E., Codogno, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4999 · Cited by 55
Disruption of Lysosome Function Promotes Tumor Growth and Metastasis in Drosophila
Chi, C., Zhu, H., Han, M., Zhuang, Y., Wu, X., & Xu, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.131714 · Cited by 51
Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives
Zhang, H., Solomon, V. R., Hu, C., Ulíbarri, G., & Lee, H. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.04.007 · Cited by 51
Loehberg, C. R., Strissel, P. L., Dittrich, R., Strick, R., Dittmer, J., Dittmer, A., Fabry, B., Kalender, W. A., Koch, T., Wachter, D. L., et al. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.11.022 · Cited by 50
Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
Tang, M., Wu, M., Hwang, M.-H., Chang, Y.-T., Huang, H.-J., Lin, A. M.-Y., & Yang, J. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119135 · Cited by 49
Bokobza, S., Jiang, Y., Weber, A. M., Devery, A., & Ryan, A. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2017 · Cited by 46
Chloroquine Engages the Immune System to Eradicate Irradiated Breast Tumors in Mice
Ratikan, J. A., Sayre, J. W., & Schaue, D. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.07.024 · Cited by 44
Integrating autophagy and metabolism in cancer
Cheong, H. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0562-2 · Cited by 44
Chi, K., Ko, H., Yang, K., Lee, C.-Y., Chi, M., & Kao, S. (2015) · Oncotarget · doi:10.18632/oncotarget.3793 · Cited by 40
Functional expression of TLR9 in esophageal cancer
Zhang, Y., WANG, Q., Ma, A., Li, Y., Li, R., & Wang, Y. (2014) · Oncology Reports · doi:10.3892/or.2014.3095 · Cited by 40
Park, B. C., Park, S. H., Paek, S., Park, S., Kwak, M., Choi, H. G., Yong, C. S., Yoo, B. K., & Kim, J. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.02.003 · Cited by 40
Kaneko, M., Nozawa, H., Hiyoshi, M., Tada, N., Murono, K., Nirei, T., Emoto, S., Kishikawa, J., Iida, Y., Sunami, E., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1628-0 · Cited by 39
Sandholm, J. A., Tuomela, J. M., Kauppila, J. H., Harris, K. W., Graves, D. E., & Selander, K. S. (2014) · Oncology Letters · doi:10.3892/ol.2014.2095 · Cited by 36
Chloroquine Promotes the Anticancer Effect of TACE in a Rabbit VX2 Liver Tumor Model
Gao, L., Song, J., Zhang, J.-W., Zhao, X., Zhao, Q., Sun, K., Deng, W.-J., Li, R., Lv, G., Cheng, H.-Y., et al. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.5925 · Cited by 36
Vessoni, A. T., Quinet, A., de Andrade-Lima, L. C., Martins, D. J., Garcia, C. C. M., Rocha, C. R. R., Vieira, D. B., & Menck, C. F. M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.008 · Cited by 35
The inhibition of gluconeogenesis by chloroquine contributes to its hypoglycaemic action
Jarzyna, R., Kiersztan, A., Lisowa, O., & Bryła, J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01221-3 · Cited by 34
Lagneaux, L., Delforge, A., Carlier, S., Massy, M., Bernier, M., & Bron, D. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02553.x · Cited by 32
Gaudin, D., Yielding, K. L., Stabler, A., et al. (1971) · Experimental Biology and Medicine · doi:10.3181/00379727-137-35544 · Cited by 32
Lagneaux, L., Delforge, A., Dejeneffe, M., Massy, M., Bernier, M., & Bron, D. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290021506 · Cited by 31
Zhang, Y., Li, Y., Li, Y., Li, R., MA, Y., Wang, H., & WANG, Y. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2839 · Cited by 27
Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer
Tuomela, J. M., Sandholm, J. A., Kauppila, J. H., Lehenkari, P. P., Harris, K. W., & Selander, K. S. (2013) · Oncology Letters · doi:10.3892/ol.2013.1602 · Cited by 27
Seront, E., Boidot, R., Bouzin, C., Karroum, O., Jordan, B. F., Gallez, B., Machiels, J.-P., & Féron, O. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.644 · Cited by 26
Double autophagy modulators reduce 2-deoxyglucose uptake in sarcoma patients
Chi, M., Lee, C.-Y., Huang, S.-C., Yang, K.-L., Ko, H.-L., Chen, Y., Chung, C.-H., Liao, K., & Chi, K.-H. (2015) · Oncotarget · doi:10.18632/oncotarget.5060 · Cited by 26
FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma
Bilger, A., Bittner, M.-I., Grosu, A., Wiedenmann, N. E., Meyer, P. T., Firat, E., Niedermann, G., Weber, W., & Milanović, D. (2014) · Strahlentherapie und Onkologie · doi:10.1007/s00066-014-0693-2 · Cited by 26
Mouse Models Address Key Concerns Regarding Autophagy Inhibition in Cancer Therapy
Amaravadi, R. K., & Debnath, J. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0618 · Cited by 25
Battisti, S., Valente, D., Albonici, L., Bei, R., Modesti, A., & Palumbo, C. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0195oc · Cited by 23
Autophagy sensitivity of neuroendocrine lung tumor cells
Hong, S., Kim, J. H., Starenki, D., & Park, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2136 · Cited by 23
Shoemaker, J. P., & Dagher, R. K. (1979) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/62.6.1575 · Cited by 23
Dynamic interplay between autophagic flux and A kt during melanoma progression in vitro
Maes, H., Martín-Acebes, M. A., Verfaillie, T., & Agostinis, P. (2013) · Experimental Dermatology · doi:10.1111/exd.12298 · Cited by 21
Self-citationInhibitory Properties of Nerve-Specific Human Glutamate Dehydrogenase Isozyme by Chloroquine
Choi, M., Kim, E.-A. L., Choi, S.-Y., Kim, T.-U., Cho, S., & Yang, S.-J. (2007) · BMB Reports · doi:10.5483/bmbrep.2007.40.6.1077 · Cited by 21
New Treatments for Malignant Gliomas: Careful Evaluation and Cautious Optimism Required
Gilbert, M. R. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00015 · Cited by 19
Using BRAFV600Eas a marker of autophagy dependence in pediatric brain tumors
Levy, J. M. M., Foreman, N. K., & Thorburn, A. M. (2014) · Autophagy · doi:10.4161/auto.36138 · Cited by 19
Maes, H., Kuchnio, A., Carmeliet, P., & Agostinis, P. (2014) · Autophagy · doi:10.4161/auto.36259 · Cited by 17
Self-citationKyle, R. A., Br, S., Hj, W., Silver, R., Glidewell, O. J., & Jf, H. (1975) · PubMed · Cited by 16
Interaction of VP16-213 with the DNA repair antagonist chloroquine
Arnold, A., & Whitehouse, J. M. A. (1982) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00254533 · Cited by 14
Chloroquine Exerts Anti-metastatic Activities Under Hypoxic Conditions in Cholangiocarcinoma Cells
Thongchot, S., Loilome, W., Yongvanit, P., Dokduang, H., Thanan, R., Techasen, A., & Namwat, N. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.5.2031 · Cited by 14
Triggering Liposomal Drug Release With a Lysosomotropic Agent
Xiong, S., Li, H., Yu, B., Wu, J. H., & Lee, R. J. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22210 · Cited by 12
Enhanced growth of mammary adenocarcinoma in rats by chloroquine and quinacrine
Dutta, P., Karmali, R. A., Pinto, J. T., et al. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90386-7 · Cited by 7
Of autophagy and in vivo pancreatic carcinogenesis: The p53 status matters!
Jonckheere, N., Vincent, A., & SEUNINGEN, I. V. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.04.009 · Cited by 6
PUMA: A Puzzle Piece in Chloroquine’s Antimelanoma Activity
Amaravadi, R. K. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.135 · Cited by 6
Cited by
Lysosomal membrane permeabilization and cell death
Wang, F., Gómez‐Sintes, R., & Boya, P. (2018) · Traffic · doi:10.1111/tra.12613 · Cited by 776
Complex interplay between autophagy and oxidative stress in the development of pulmonary disease
Ornatowski, W., Lu, Q., Yegambaram, M., Garcia, A. E., Zemskov, E. A., Maltepe, E., Fineman, J. R., Wang, T., & Black, S. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101679 · Cited by 467
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications
Nazio, F., Bordi, M., Cianfanelli, V., Locatelli, F., & Cecconi, F. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-019-0292-y · Cited by 388
Patergnani, S., Danese, A., Bouhamida, E., Aguiari, G., Previati, M., Pinton, P., & Giorgi, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218323 · Cited by 350
Plantone, D., & Koudriavtseva, T. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0656-y · Cited by 305
Metadata
- Authors
- Verbaanderd, C., Maes, H., Schaaf, M. B., Sukhatme, V. P., Pantziarka, P., Sukhatme, V., Agostinis, P., & Bouche, G.
- Venue
- ecancermedicalscience
- Publisher
- Ecancer Global Foundation
- Published
- 2017-11-23
- Volume
- 11
- Pages
- 781-781
- ISSN
- 1754-6605 (ISSN-L)
- OpenAlex
- W2768197901
- Cited by
- 275
- References
- 172
- FWCI
- 17.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.